AIM: To estimate the prevalence of Alzheimer's disease (AD) and other dementias in the USA using a nationally representative sample. METHODS: The Aging, Demographics, and Memory Study sample was composed of 856 individuals aged 71 years and older from the nationally representative Health and Retirement Study (HRS) who were evaluated for dementia using a comprehensive in-home assessment. An expert consensus panel used this information to assign a diagnosis of normal cognition, cognitive impairment but not demented, or dementia (and dementia subtype). Using sampling weights derived from the HRS, we estimated the national prevalence of dementia, AD and vascular dementia by age and gender. RESULTS: The prevalence of dementia among individuals aged 71 and older was 13.9%, comprising about 3.4 million individuals in the USA in 2002. The corresponding values for AD were 9.7% and 2.4 million individuals. Dementia prevalence increased with age, from 5.0% of those aged 71-79 years to 37.4% of those aged 90 and older. CONCLUSIONS: Dementia prevalence estimates from this first nationally representative population-based study of dementia in the USA to include subjects from all regions of the country can provide essential information for effective planning for the impending healthcare needs of the large and increasing number of individuals at risk for dementia as our population ages. (c) 2007 S. Karger AG, Basel.
AIM: To estimate the prevalence of Alzheimer's disease (AD) and other dementias in the USA using a nationally representative sample. METHODS: The Aging, Demographics, and Memory Study sample was composed of 856 individuals aged 71 years and older from the nationally representative Health and Retirement Study (HRS) who were evaluated for dementia using a comprehensive in-home assessment. An expert consensus panel used this information to assign a diagnosis of normal cognition, cognitive impairment but not demented, or dementia (and dementia subtype). Using sampling weights derived from the HRS, we estimated the national prevalence of dementia, AD and vascular dementia by age and gender. RESULTS: The prevalence of dementia among individuals aged 71 and older was 13.9%, comprising about 3.4 million individuals in the USA in 2002. The corresponding values for AD were 9.7% and 2.4 million individuals. Dementia prevalence increased with age, from 5.0% of those aged 71-79 years to 37.4% of those aged 90 and older. CONCLUSIONS:Dementia prevalence estimates from this first nationally representative population-based study of dementia in the USA to include subjects from all regions of the country can provide essential information for effective planning for the impending healthcare needs of the large and increasing number of individuals at risk for dementia as our population ages. (c) 2007 S. Karger AG, Basel.
Authors: Cleusa P Ferri; Martin Prince; Carol Brayne; Henry Brodaty; Laura Fratiglioni; Mary Ganguli; Kathleen Hall; Kazuo Hasegawa; Hugh Hendrie; Yueqin Huang; Anthony Jorm; Colin Mathers; Paulo R Menezes; Elizabeth Rimmer; Marcia Scazufca Journal: Lancet Date: 2005-12-17 Impact factor: 79.321
Authors: H C Hendrie; B O Osuntokun; K S Hall; A O Ogunniyi; S L Hui; F W Unverzagt; O Gureje; C A Rodenberg; O Baiyewu; B S Musick Journal: Am J Psychiatry Date: 1995-10 Impact factor: 18.112
Authors: Annette L Fitzpatrick; Lewis H Kuller; Diane G Ives; Oscar L Lopez; William Jagust; John C S Breitner; Beverly Jones; Constantine Lyketsos; Corinne Dulberg Journal: J Am Geriatr Soc Date: 2004-02 Impact factor: 5.562
Authors: L J Launer; K Andersen; M E Dewey; L Letenneur; A Ott; L A Amaducci; C Brayne; J R Copeland; J F Dartigues; P Kragh-Sorensen; A Lobo; J M Martinez-Lage; T Stijnen; A Hofman Journal: Neurology Date: 1999-01-01 Impact factor: 9.910
Authors: L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn Journal: JAMA Date: 1997 Oct 22-29 Impact factor: 56.272
Authors: Philippa J Clarke; Jennifer A Ailshire; James S House; Jeffrey D Morenoff; Katherine King; Robert Melendez; Kenneth M Langa Journal: J Epidemiol Community Health Date: 2011-04-22 Impact factor: 3.710
Authors: Frederick W Unverzagt; Lin T Guey; Richard N Jones; Michael Marsiske; Jonathan W King; Virginia G Wadley; Michael Crowe; George W Rebok; Sharon L Tennstedt Journal: J Int Neuropsychol Soc Date: 2012-03-09 Impact factor: 2.892
Authors: Laura F Defina; Benjamin L Willis; Nina B Radford; Ang Gao; David Leonard; William L Haskell; Myron F Weiner; Jarett D Berry Journal: Ann Intern Med Date: 2013-02-05 Impact factor: 25.391
Authors: Pei-Jung Lin; Joanna Emerson; Jessica D Faul; Joshua T Cohen; Peter J Neumann; Howard M Fillit; Allan T Daly; Nikoletta Margaretos; Karen M Freund Journal: J Am Geriatr Soc Date: 2020-04-13 Impact factor: 5.562
Authors: Mary A M Rogers; Brenda L Plassman; Mohammed Kabeto; Gwenith G Fisher; John J McArdle; David J Llewellyn; Guy G Potter; Kenneth M Langa Journal: J Geriatr Psychiatry Neurol Date: 2008-12-10 Impact factor: 2.680